103 related articles for article (PubMed ID: 6527276)
1. Electrostatic effects in acylation of hemoglobin by aspirins.
Massil SE; Shi GY; Klotz IM
J Pharm Sci; 1984 Dec; 73(12):1851-3. PubMed ID: 6527276
[TBL] [Abstract][Full Text] [Related]
2. Alternative diaspirins for modification of hemoglobin and sickle hemoglobin.
Delaney EJ; Massil SE; Shi GY; Klotz IM
Arch Biochem Biophys; 1984 Feb; 228(2):627-38. PubMed ID: 6696450
[TBL] [Abstract][Full Text] [Related]
3. Diaspirins that cross-link beta chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate.
Walder JA; Zaugg RH; Walder RY; Steele JM; Klotz IM
Biochemistry; 1979 Oct; 18(20):4265-70. PubMed ID: 486423
[TBL] [Abstract][Full Text] [Related]
4. Diaspirins of methylenecitric acid.
Massil SE; Shi GY; Klotz IM
J Pharm Sci; 1984 Mar; 73(3):418-20. PubMed ID: 6716258
[TBL] [Abstract][Full Text] [Related]
5. Acylation of hemoglobin by aspirin-like diacyl esters.
Massil SE; Shi GY; Klotz IM
J Pharm Sci; 1984 Jul; 73(7):1013-4. PubMed ID: 6470944
[TBL] [Abstract][Full Text] [Related]
6. Structural specificities in acylation of hemoglobin and sickle hemoglobin by diaspirins.
Wood LE; Haney DN; Patel JR; Clare SE; Shi GY; King LC; Klotz IM
J Biol Chem; 1981 Jul; 256(13):7046-52. PubMed ID: 7240262
[TBL] [Abstract][Full Text] [Related]
7. O-carbamoylsalicylates: agents for modification of hemoglobins.
Parameswaran KN; Shi GY; Klotz IM
J Med Chem; 1987 May; 30(5):936-9. PubMed ID: 3572982
[TBL] [Abstract][Full Text] [Related]
8. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
[TBL] [Abstract][Full Text] [Related]
9. Reye's syndrome: salicylates and mitochondrial functions.
Martens ME; Lee CP
Biochem Pharmacol; 1984 Sep; 33(18):2869-76. PubMed ID: 6477646
[TBL] [Abstract][Full Text] [Related]
10. Aspirins and enzymes.
Smith MJ
Lancet; 1968 Oct; 2(7572):828. PubMed ID: 4175620
[No Abstract] [Full Text] [Related]
11. Modification of hemoglobin with analogs of aspirin.
Zaugg RH; Walder JA; Walder RY; Steele JM; Klotz IM
J Biol Chem; 1980 Apr; 255(7):2816-21. PubMed ID: 7358711
[TBL] [Abstract][Full Text] [Related]
12. Acylation of human hemoglobin with polyoxyethylene derivatives.
Leonard M; Dellacherie E
Biochim Biophys Acta; 1984 Dec; 791(2):219-25. PubMed ID: 6509065
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the in vitro anti-aggregating action of various salicylic derivatives].
Sánchez MS; García Rafanell J; Forn J
Arch Farmacol Toxicol; 1981 Apr; 7(1):89-92. PubMed ID: 7325722
[No Abstract] [Full Text] [Related]
14. Bovine hemoglobin as a potential source of hemoglobin-based oxygen carriers: crosslinking with bis(2,3-dibromosalycyl)fumarate.
Fronticelli C; Sato T; Orth C; Bucci E
Biochim Biophys Acta; 1986 Nov; 874(1):76-81. PubMed ID: 3768378
[TBL] [Abstract][Full Text] [Related]
15. Aspirin acetylation of betaLys-82 of human hemoglobin. NMR study of acetylated hemoglobin Tsurumai.
Xu AS; Ohba Y; Vida L; Labotka RJ; London RE
Biochem Pharmacol; 2000 Oct; 60(7):917-22. PubMed ID: 10974199
[TBL] [Abstract][Full Text] [Related]
16. Effect of other hemoglobins on gelation of sickle cell hemoglobin.
Sunshine HR
Tex Rep Biol Med; 1980-1981; 40():233-50. PubMed ID: 6172866
[No Abstract] [Full Text] [Related]
17. Inactivation of enzymes by therapeutic concentrations of aspirin and salicylate.
Grisolia S; Mendelson J; Diederich D
Nature; 1969 Jul; 223(5201):79-80. PubMed ID: 5792437
[No Abstract] [Full Text] [Related]
18. Chemical and pharmacological properties of diflunisal.
Shen TY
Pharmacotherapy; 1983; 3(2 Pt 2):3S-8S. PubMed ID: 6856488
[TBL] [Abstract][Full Text] [Related]
19. Acetoxy benzene derivatives: in vitro antiaggregant activity.
Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
Farmaco Sci; 1986 Dec; 41(12):934-41. PubMed ID: 3556567
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
